Variant | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AF EXOME | AF GENOME | Disease | Disease Class | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
20 | 41182635 | 3 prime UTR variant | G/C;T | snv |
|
0.700 | 1.000 | 3 | 2010 | 2019 | |||||||||||
|
0.925 | 0.120 | 20 | 41163423 | missense variant | A/G | snv | 0.14 | 0.14 |
|
Mental Disorders | 0.700 | 1.000 | 1 | 2016 | 2016 | ||||||
|
20 | 41179129 | 3 prime UTR variant | G/A | snv | 3.6E-02 |
|
0.700 | 1.000 | 1 | 2019 | 2019 | ||||||||||
|
20 | 41182635 | 3 prime UTR variant | G/C;T | snv |
|
0.700 | 1.000 | 1 | 2018 | 2018 | |||||||||||
|
1.000 | 0.040 | 20 | 41193692 | intron variant | T/G | snv | 0.29 |
|
Cardiovascular Diseases | 0.700 | 1.000 | 1 | 2018 | 2018 | |||||||
|
20 | 41168825 | missense variant | T/C | snv | 0.61 | 0.67 |
|
Pathological Conditions, Signs and Symptoms | 0.700 | 1.000 | 1 | 2019 | 2019 | ||||||||
|
20 | 41168825 | missense variant | T/C | snv | 0.61 | 0.67 |
|
0.700 | 1.000 | 1 | 2012 | 2012 | |||||||||
|
20 | 41168825 | missense variant | T/C | snv | 0.61 | 0.67 |
|
0.700 | 1.000 | 1 | 2016 | 2016 | |||||||||
|
0.851 | 0.120 | 20 | 41147406 | intron variant | C/A;T | snv | 0.59 |
|
0.700 | 1.000 | 1 | 2016 | 2016 | ||||||||
|
0.851 | 0.120 | 20 | 41147406 | intron variant | C/A;T | snv | 0.59 |
|
0.700 | 1.000 | 1 | 2016 | 2016 | ||||||||
|
0.851 | 0.120 | 20 | 41147406 | intron variant | C/A;T | snv | 0.59 |
|
Nervous System Diseases; Cardiovascular Diseases | 0.700 | 1.000 | 1 | 2016 | 2016 | |||||||
|
0.851 | 0.120 | 20 | 41147406 | intron variant | C/A;T | snv | 0.59 |
|
0.700 | 1.000 | 1 | 2016 | 2016 | ||||||||
|
0.851 | 0.120 | 20 | 41147406 | intron variant | C/A;T | snv | 0.59 |
|
Cardiovascular Diseases | 0.700 | 1.000 | 1 | 2016 | 2016 | |||||||
|
0.851 | 0.120 | 20 | 41147406 | intron variant | C/A;T | snv | 0.59 |
|
Endocrine System Diseases | 0.700 | 1.000 | 1 | 2016 | 2016 | |||||||
|
0.851 | 0.120 | 20 | 41147406 | intron variant | C/A;T | snv | 0.59 |
|
Neoplasms | 0.700 | 1.000 | 1 | 2016 | 2016 | |||||||
|
0.851 | 0.120 | 20 | 41147406 | intron variant | C/A;T | snv | 0.59 |
|
0.700 | 1.000 | 1 | 2016 | 2016 | ||||||||
|
0.851 | 0.120 | 20 | 41147406 | intron variant | C/A;T | snv | 0.59 |
|
0.700 | 1.000 | 1 | 2016 | 2016 | ||||||||
|
0.851 | 0.120 | 20 | 41147406 | intron variant | C/A;T | snv | 0.59 |
|
0.700 | 1.000 | 1 | 2016 | 2016 | ||||||||
|
0.851 | 0.120 | 20 | 41147406 | intron variant | C/A;T | snv | 0.59 |
|
0.700 | 1.000 | 1 | 2016 | 2016 | ||||||||
|
0.851 | 0.120 | 20 | 41147406 | intron variant | C/A;T | snv | 0.59 |
|
Cardiovascular Diseases | 0.700 | 1.000 | 1 | 2016 | 2016 | |||||||
|
0.851 | 0.120 | 20 | 41147406 | intron variant | C/A;T | snv | 0.59 |
|
0.700 | 1.000 | 1 | 2016 | 2016 | ||||||||
|
0.851 | 0.120 | 20 | 41147406 | intron variant | C/A;T | snv | 0.59 |
|
Nutritional and Metabolic Diseases; Endocrine System Diseases | 0.700 | 1.000 | 1 | 2016 | 2016 | |||||||
|
0.851 | 0.120 | 20 | 41147406 | intron variant | C/A;T | snv | 0.59 |
|
0.700 | 1.000 | 1 | 2016 | 2016 | ||||||||
|
0.851 | 0.120 | 20 | 41147406 | intron variant | C/A;T | snv | 0.59 |
|
Pathological Conditions, Signs and Symptoms; Cardiovascular Diseases | 0.700 | 1.000 | 1 | 2016 | 2016 | |||||||
|
0.925 | 0.120 | 20 | 41161795 | intron variant | C/T | snv | 4.4E-02 |
|
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Endocrine System Diseases | 0.010 | 1.000 | 1 | 2014 | 2014 |